Citation Impact
Citing Papers
Structural basis for triplet repeat disorders: a computational analysis
1999 StandoutNobel
Effects of Perceived Treatment on Quality of Life and Medical Outcomesin a Double-blind Placebo Surgery Trial
2004
Can a Screening Questionnaire Accurately Identify Mild Parkinsonian Signs
2012
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Celastrols as Inducers of the Heat Shock Response and Cytoprotection
2004 Standout
Alterations in opioid receptor binding in Parkinson's disease patients with levodopa‐induced dyskinesias
1997
Excitotoxic injury of the neostriatum: a model for Huntington's disease
1990
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Autism: Towards an Integration of Clinical, Genetic, Neuropsychological, and Neurobiological Perspectives
1996 Standout
Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
2012 Standout
Therapeutic opportunities in polyglutamine disease
2001
Parkinson's Disease
1998 Standout
The therapeutic potential of G-protein coupled receptors in Huntington's disease
2010
From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease
2010
Redox Control of Protein Kinase C: Cell- and Disease-Specific Aspects
2010
Huntington??s Disease
1999
A Comprehensive Review of the Placebo Effect: Recent Advances and Current Thought
2007 Standout
Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis
2019 Standout
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
1993 StandoutScience
Trinucleotide repeat length and progression of illness in Huntington's disease.
1994
The prevalence of Parkinson's disease: A systematic review and meta‐analysis
2014 Standout
Works of Sandra Plumb being referenced
A controlled trial of propoxyphene and naltrexone in patients with tourette's syndrome
1991
Rasagiline improves quality of life in patients with early Parkinson's disease
2006
A controlled clinical trial of baclofen as protective therapy in early huntington's disease
1989
Test–Retest reliability of the Unified Parkinson's Disease Rating Scale in patients with early Parkinson's disease: Results from a multicenter clinical trial
2002